1. Home
  2. BELFB vs SUPN Comparison

BELFB vs SUPN Comparison

Compare BELFB & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc. Class B

BELFB

Bel Fuse Inc. Class B

HOLD

Current Price

$254.51

Market Cap

3.5B

Sector

N/A

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.66

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BELFB
SUPN
Founded
1949
2005
Country
United States
United States
Employees
4964
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
BELFB
SUPN
Price
$254.51
$48.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$174.25
$61.60
AVG Volume (30 Days)
250.0K
646.7K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
0.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$9.74
$22.70
Revenue Next Year
$6.34
$19.14
P/E Ratio
$42.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$70.87
$31.16
52 Week High
$308.27
$59.68

Technical Indicators

Market Signals
Indicator
BELFB
SUPN
Relative Strength Index (RSI) 46.66 45.26
Support Level $241.14 $47.73
Resistance Level $308.27 $52.36
Average True Range (ATR) 14.22 2.17
MACD -6.15 -0.18
Stochastic Oscillator 14.01 29.80

Price Performance

Historical Comparison
BELFB
SUPN

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: